JUN 24, 2019 02:36 PM PDT

Drug Combination May Combat Deadly Drug-Resistant Fungus

WRITTEN BY: Nouran Amin

A drug combination of anti-fungal and anti-bacterial medications may be effective against the spread of a highly infectious and deadly fungus--Candida auris (C. auris). According to the Centers for Disease and Control, C. auris was first discovered in Japan and has affected individuals in more than 20 countries and sickened 643 Americans in 11 U.S. states. The fungus has baffled health officials as the search for treatment options are higher than ever.

"Few treatment options are available for patients infected with Candida auris, which causes invasive, life-threatening infections, usually in patients who are already critically ill or have compromised immune systems," said Brennan-Krohn, MD, a post-doctoral research fellow in the lab of James E. Kirby, MD, Director of the Clinical Microbiology Laboratory at BIDMC. "It has an alarming propensity to spread from patient to patient and survive on surfaces in rooms, resulting in hospital outbreaks."

Findings presented at the annual meeting of the American Society for Microbiology discuss how the search for new treatment approaches allowed researchers to use a modified inkjet printer. The modified inkjet printer allows for rapid and uniform antimicrobial screening for the testing of antifungal drugs, amphotericin and caspofungin, in combination with two antibacterial antibiotics antibiotics, minocycline and rifampin,—to maximize the efficacy against fungal infections. Results showed three new combinations of antifungal and antibacterial drugs that demonstrated effectiveness against C. auris.

Although the dugs have not been tested in combination in C. auris-infected humans, the drugs are actually FDA-approved and presently prescribed for patients with a variety of infections.

However, if the drugs prove to eradicate C. auris infections in clinical studies, then physicians already have access to the effective treatment for their patients infected with C. auris.

Source: Science Daily

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUL 18, 2019
Drug Discovery
JUL 18, 2019
Injectable Medicine Improves Genetic Rickets
A recent study found that an injectable medicine called ‘Burosumab’ was shown to improve symptoms of X-linked hypophosphatemia (XLH)--an inheri...
JUL 18, 2019
Genetics & Genomics
JUL 18, 2019
The Power and Responsibility of Using CRISPR
      What makes CRISPR so powerful is that it is easy for any molecular or genetic scientist to use, and it works on almost every cell...
JUL 18, 2019
Drug Discovery
JUL 18, 2019
Nanomachine Improves Drug Delivery for Cancer Therapeutics
Recent studies on mice has allowed researchers to find a way to deliver specific drugs to certain parts of the body that are exceptionally difficult to acc...
JUL 18, 2019
Drug Discovery
JUL 18, 2019
Anti-Hypertensive Drug Use and Dementia?
A soon to be published study investigated the relationship between antihypertensive drug use and dementia in older adults. The study derived data from the ...
JUL 18, 2019
Drug Discovery
JUL 18, 2019
Experimental Drug Encourages Bone Growth in Children with Dwarfism
An experimental drug called vosoritide, alters certain proteins that block bone growth, which allowed the average annual growth of bone in a study of 35 ch...
JUL 18, 2019
Health & Medicine
JUL 18, 2019
High Risk: Seizures and Coma Linked to Use of Synthetic Cannabinoids in Adolescents
A recent study by the American Academy of Pediatrics states that exposure to acute synthetic cannabinoid toxicity is far more dangerous to the adolesc...
Loading Comments...